Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

This is some text inside of a div block.
This is some text inside of a div block.

Problem Tech Solves

Tech Brief

Managing chronic and rare respiratory diseases is challenging for patients, caregivers and those who provide and enable their care. Patients want to experience fewer symptoms to live fuller lives and get back to doing the things they love, but may forget to take their medications regularly or feel too overwhelmed to stay motivated. Caregivers want peace of mind that their loved ones are doing well, but feel helpless when they can’t support them in person. Providers, health systems and payers seek to provide the best possible care for their patients, but often lack clinical resources and insights into how patient populations are self-managing their conditions at home. Propeller’s precision digital health platform offers a clinically-proven solution to these crises by empowering patients with the resources they need to better manage their health, providing caregivers the tools to monitor their loved ones’ conditions, and enabling healthcare organizations with the objective patient behavior and medication use data they need to optimize their care. By taking the guesswork out of understanding patient adherence and disease control, clinicians can proactively identify their most at-risk patients and make more informed treatment decisions, and health systems and payers can focus finite resources on patients who need it most. When patients are surrounded with this continuous support and care connections, they become more engaged in self-managing their condition and stay motivated to take actions that will largely impact their overall health, such as taking their medications on time.

Tech Differentiators

Propeller’s greatest superpower is our ability to enable the transition toward value-based care by aligning the interests of all key players in healthcare – providers, payers and pharmaceutical companies – while keeping patients centered. As an industry, we’ve spent decades discussing the benefits of value based care: better-informed patients, higher patient satisfaction and improved patient health outcomes; and even its collateral benefits, like how it can combat rising national healthcare costs and potentially help address the health equity crisis. However, without the right business incentives for stakeholders to implement solutions that enable value-based care in practice, the vision of moving away from traditional fee-for-service models, a historically inefficient payment system, is much more distant. Our precision digital health platform is uniquely positioned to facilitate the synergy between what’s best for provider, payer, and pharma businesses, and what’s best for patients. We are already seeing this prove itself out: Propeller’s digital health solution enables thoughtful data collection that allows for a more holistic patient experience, while providing actionable insights to providers, payers and pharma companies. These objective insights simultaneously empower providers to make more informed treatment decisions with individual patients (without straining finite clinical resources), help payers effectively evaluate care outcomes at a population health level (at lower system costs), and enable pharma companies to precisely identify eligible patient groups for treatments.


For more than 10 years, the effectiveness of our approach, platform and products have been validated across diverse geographies, clinical settings and patient populations. With 50+ peer-reviewed publications and 100+ peer-reviewed published abstracts, we’ve set the standard in clinical research for digital respiratory care. Our most notable clinical outcomes include: Reduced healthcare utilization: - A 57% reduction in asthma-related emergency department visits and hospitalizations was observed among 224 children and adults with uncontrolled disease status (Merchant et al. 2018, World Allergy Organ J). - A 35% decline in COPD-related emergency department visits and hospitalizations was observed among 39 patients (Alshabani et al. 2019, J Telemedicine and Telecare). Improved medication adherence: - In a randomized control trial with 125 asthma patients, Propeller users had an average medication adherence of 58%, a 22% improvement compared to the control group (Van Sickle et al. 2016, Eur Resp J). Reduced rescue inhaler use: - 495 children and adults with asthma who used Propeller demonstrated up to an 18.5% reduction in rescue inhaler use compared to a control group (Merchant et al. 2016. J Allergy Clin Immunol Pract). - In an observational study with 190 medicare-eligible patients with COPD, patients experienced a 63% decrease in daily rescue inhaler use, a 73% reduction in nighttime rescue use and a 36% increase in days without rescue use (Chen et al. 2019. JMIR Form Res).

Why Us